Skip to content

IPSC

Century Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.11
+0.96%
Ask drillr
0
Insider buys (3m)
5
Insider sells (3m)
-$11.6K
Net value (3m)
-0.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 18, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind31,172$1.92
Aug 5, 2026Carr Douglas · officer: SVP Finance & OperationsSale275$1.98
Jun 15, 2026Carr Douglas · officer: SVP Finance & OperationsSale1,654$2.23
Jun 15, 2026Cowan Chad · officer: Chief Scientific OfficerF-InKind358$2.24
Jun 15, 2026Russotti Gregory · officer: See RemarksSale2,584$2.23
Jun 15, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind13,849$2.24
Jun 12, 2026Blackwell Kimberly · directorA-Award74,000$2.24
Jun 12, 2026Lee Han Myung · directorA-Award74,000$2.24
Jun 12, 2026Murphy Martin Patrick · directorA-Award74,000$2.24
Jun 12, 2026Quimi Daphne · directorA-Award74,000$2.24
Jun 12, 2026Riva Alessandro · directorA-Award74,000$2.24
Jun 9, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind463$2.13
Jun 9, 2026Russotti Gregory · officer: See RemarksSale524$2.11
Jun 9, 2026Carr Douglas · officer: SVP Finance & OperationsSale249$2.11
May 19, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind31,172$2.34
May 6, 2026Carr Douglas · officer: SVP Finance & OperationsSale264$2.34
Apr 10, 2026Murphy Martin Patrick · directorA-Award88,000$0.59
Apr 3, 2026Cowan Chad · officer: Chief Scientific OfficerF-InKind1,365$2.19
Mar 16, 2026Carr Douglas · officer: SVP Finance & OperationsSale7,043$2.55
Mar 16, 2026Russotti Gregory · officer: See RemarksSale10,076$2.55
Mar 13, 2026Cowan Chad · officer: Chief Scientific OfficerF-InKind1,431$2.73
Mar 13, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind55,397$2.73
Mar 11, 2026Russotti Gregory · officer: See RemarksSale479$2.54
Mar 10, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind463$2.56
Feb 18, 2026Pfeiffenberger Brent · director, officer: President and CEOF-InKind31,172$1.75
Feb 5, 2026Carr Douglas · officer: SVP Finance & OperationsSale323$1.82
Feb 4, 2026Pfeiffenberger Brent · director, officer: President and CEOA-Award475,000$0.00
Feb 4, 2026Carr Douglas · officer: SVP Finance & OperationsA-Award225,000$1.84
Feb 4, 2026Carr Douglas · officer: SVP Finance & OperationsA-Award110,000$0.00
Feb 4, 2026Cowan Chad · officer: Chief Scientific OfficerA-Award265,000$1.84
Institutional positioning

13F filings over the trailing two quarters

New 32Increased 17Reduced 13Sold out 74
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.New Position17,754,430May 15, 2026
TCG CROSSOVER MANAGEMENT, LLCNew Position17,754,430May 15, 2026
VERSANT VENTURE MANAGEMENT, LLCNew Position12,166,109May 5, 2026
DEEP TRACK CAPITAL, LPNew Position9,487,745May 15, 2026
RTW INVESTMENTS, LPNew Position8,695,652May 15, 2026
VR ADVISER, LLCNew Position8,695,652May 15, 2026
COMMODORE CAPITAL LPNew Position8,695,652May 15, 2026
POINT72 ASSET MANAGEMENT, L.P.Increased5,964,678May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position5,686,204May 15, 2026
BALYASNY ASSET MANAGEMENT L.P.New Position5,017,733May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased4,667,063May 15, 2026
Spruce Street Capital LPIncreased4,059,054May 14, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Increased3,789,538May 15, 2026
WOODLINE PARTNERS LPNew Position3,043,478May 15, 2026
Seven Fleet Capital Management LPNew Position2,947,826Jun 4, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026